Mitomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-502

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mitomycin (NDC 68083-502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mitomycin-spl-carton-label (Mitomycin Spl Carton Label)

The text is a label for a medication called Mitomycin for Injection, USP. The label warns that the medication must be administered intravenously to avoid tissue damage and is a cytotoxic agent. The contents of the single-dose vial contain 40mg of Mitomycin and 80mg of Mannitol. The medication should be prepared by adding 80mL of sterile water to the vial and shaking to dissolve. The reconstituted solution must be stored in the refrigerator and protected from light. The label provides instructions on the dosing and storage of the medication. The medication is manufactured by Gland Pharma Limited in Visakhapatnam, Andhra Pradesh, India.*

FDA Label Image

Container-label (Mitomycin Spl Container Label)

Mitomycin is a cytotoxic agent that comes in a 40mg/vial for injection. The product is intended for intravenous use only and caution must be exercised when administering this product to avoid tissue damage. The warning label contains important safety information.*

FDA Label Image

Mitomycin-spl-structure (Mitomycin Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.